Skip to content

Reproductive Genetics

Patient inquiry acceptedScreening test

Non-Invasive Prenatal Testing (NIPT)

NIPT analyses fragments of the baby's DNA in the mother's blood to estimate the chance of common chromosomal conditions. A high-chance result should be confirmed with diagnostic testing.

Also known as: cfDNA screening · Test code: NIPT-01

  • Sample

    Blood

  • Method

    Next Generation Sequencing (NGS)

  • Turnaround

    21 days

About this test

NIPT analyses fragments of the baby's DNA in the mother's blood to estimate the chance of common chromosomal conditions. A high-chance result should be confirmed with diagnostic testing.

A referral from your doctor is not essential. You can do the test through a referral from your doctor or request the test independently (self-request).

No special preparation is usually required; completion of 10 weeks of pregnancy is recommended.

Samples can be collected at the GeneLabs X Centre in Kotte or at any of our designated sample collection centres.

This test estimates the chance of selected fetal chromosome abnormalities using placental DNA fragments in maternal blood. This is a screening test. A high-risk result requires diagnostic confirmation; a low-risk result does not exclude all genetic conditions.

Non-Invasive Prenatal Testing (NIPT) is a screening test, not a diagnostic test. Discuss your results with your doctor before making any decisions.

Need help?

Not sure this is the right test?

Our team can help you or your clinician find the right pathway.